Orange Book product · Generic (ANDA)
ISOPROTERENOL HYDROCHLORIDE
ISOPROTERENOL HYDROCHLORIDE
At a glance
Oct 03, 2024
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 03, 2024
1 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
ISOPROTERENOL HYDROCHLORIDE
Strength
0.2MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 217648
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ISOPROTERENOL HYDROCHLORIDE
- —ISOPROTERENOL HYDROCHLORIDEBrand (NDA)
NDA 010375 · 3M
- —ISUPRELBrand (NDA)
NDA 011178 · SANOFI AVENTIS US
- —NORISODRINE AEROTROLBrand (NDA)
NDA 016814 · ABBOTT
- —ISUPRELBrand (NDA)
NDA 010515 · BAUSCH
- —AEROLONEBrand (NDA)
NDA 007245 · LILLY
- —ISUPRELBrand (NDA)
NDA 006327 · SANOFI AVENTIS US
- —VAPO-ISOBrand (NDA)
NDA 016813 · FISONS
- —ISUPRELBrand (NDA)
NDA 006328 · SANOFI AVENTIS US
- 2026ISOPROTERENOL HYDROCHLORIDEGeneric (ANDA)
ANDA 220299 · ASPIRO
- 2025ISOPROTERENOL HYDROCHLORIDEGeneric (ANDA)
ANDA 213305 · DEVA HOLDING AS
- 2024ISOPROTERENOL HYDROCHLORIDEGeneric (ANDA)
ANDA 211590 · SOMERSET THERAPS LLC
- 2023ISOPROTERENOL HYDROCHLORIDEGeneric (ANDA)
ANDA 211703 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
